← Back to Search

Feedback for Multiple Myeloma

N/A
Waitlist Available
Led By Ron Paquette, MD
Research Sponsored by Cedars-Sinai Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3-4 weeks
Awards & highlights

Study Summary

This trial is testing whether or not a Fitbit can help track the fitness of patients undergoing an Autologous Stem Cell Transplant.

Eligible Conditions
  • Multiple Myeloma
  • Lymphoma
  • Transplant Rejection

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3-4 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3-4 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Fitness measured by 6 minute walk test after discharge
Secondary outcome measures
Fitness assessed by SF-36 questionnaire after discharge

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: FeedbackExperimental Treatment1 Intervention
Participants in the intervention arm will receive a Fitbit upon admission and will receive feedback from the activity tracker and the in-room TV screen as demonstrated by the Study Navigator. Study participants in this arm will be engaging with their physicians around achievement of daily step goals by viewing the in-room TV display of their daily step counts on rounds.
Group II: ControlActive Control1 Intervention
Subjects in the control arm will receive a Fitbit upon admission for their transplant but neither the physician, nurse, nor patient will receive any feedback from the device. They will be blinded to any data capture by their activity monitor. Nurses and doctors will not monitor ambulation with the activity monitor, they will use standard methods to encourage ambulation.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Feedback
2018
N/A
~18170

Find a Location

Who is running the clinical trial?

Cedars-Sinai Medical CenterLead Sponsor
498 Previous Clinical Trials
164,814 Total Patients Enrolled
2 Trials studying Multiple Myeloma
38 Patients Enrolled for Multiple Myeloma
Ron Paquette, MDPrincipal InvestigatorCedars-Sinai Medical Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Stepping Up: A Trial of Activity Monitoring Devices in Patients Undergoing Autologous Stem Cell Transplant
Ronald Paquette 2021. "Stepping Up: A Trial of Activity Monitoring Devices in Patients Undergoing Autologous Stem Cell Transplant". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04985409.
~7 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top